Dlouhy I, Maia T, Viegas D, Abreu N, Cabeçadas J, da Silva MG. Notable clinical activity of immune checkpoint inhibitors with or without brentuximab vedotin in relapsed or refractory gray zone lymphoma. Haematologica; https://doi.org/10.3324/haematol.2026.301128 [Early view].